Receptor News and Research

RSS

Genomic Database Analysis Identifies New Target for Triple-Negative Breast Tumors

Triple-negative breast cancer accounts for approximately 15% of all breast cancer cases. It is characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression, rendering it insensitive to conventional endocrine and targeted therapies.

13 Aug 2026

Newly Identified Protein Prevents T Cells From Destroying Cancer Cells

Researchers at Mayo Clinic have identified a protein that cancer cells use to suppress the body's immune response, a finding that could support the development of new treatments to improve the effectiveness of cancer immunotherapies.

5 Aug 2026

Malaria Infection Causes Permanent Damage to Resident Splenic CD163 Macrophages

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or "scavenger cells," to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne.

5 Aug 2026

Dynamic Structural Flexibility of Human Norovirus Evade the Immune System

Human norovirus is the leading cause of acute gastroenteritis worldwide and is estimated to infect 600–700 million people each year. Despite its enormous public health impact, no effective antiviral drugs are currently available.

5 Aug 2026

New Research Bypasses Rapid Fungicide Resistance Through Cell Wall Disruption

Powdery mildew is among the most widespread crop diseases, affecting cereals, grapes, cucurbits, tomatoes, fruit crops, and ornamentals in fields and greenhouses.

5 Aug 2026

Moth Wings Smell Host Plants to Identify Optimal Egg-Laying Spots

Insect wings are bristling with senses, feeling the wind blowing and even tasting potential mates, but little was known about whether moth wings are equipped with a sense of smell.

28 Jul 2026

Dengue Virus Replicates Inside Memory B Cells to Evade Immunity

Researchers at the University of Vermont Robert Larner, M.D. College of Medicine and Upstate Medical University in Syracuse, NY, have discovered that dengue virus can infect and replicate inside memory B cells, immune cells traditionally understood to help protect the body from infection.

28 Jul 2026

New Molecule Restores Muscle Repair Signal Linked to Age-Related Muscle Loss

One of the first tissues to deteriorate with aging is skeletal muscle. Weakness, scarring, internal muscle fat accumulation, and the loss of fast-twitch muscle fibers—which are crucial for rapid and forceful movements—can result from this deterioration.

27 Jul 2026

AI-Assisted Protein Tools Guide Design of Synthetic Plant Immune Receptors

Crop production faces threats from plant pathogens. Traditional disease-resistance breeding relies heavily on natural plant resistance genes that encode immune receptors adapted to particular pathogens.

24 Jul 2026

New Open Source AI Toolkit Identifies Promising Peptide Medicines

Penn Engineers have developed PeptiVerse, an AI-powered platform that predicts key chemical and biological properties of peptides, the strings of amino acids whose medical potential has been demonstrated by the success of GLP-1 drugs, the widely used weight-loss treatments.

22 Jul 2026

Study Identifies Immune Cell Failures as Aging Drivers

We may age at different rates, but none of us escapes aging.

17 Jul 2026

Researchers Discover Surprising Protective Microglia Roles in Dementia

Researchers at Trinity College Dublin have discovered that microglia – the main immune cells of the brain – play a critical role in maintaining the stability of neuronal networks in Alzheimer's disease.

16 Jul 2026

Novel T Cell Immune Path Targets Aggressive Acute Myeloid Leukemia

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (AML) cells, which may help explain why AML is particularly sensitive to immune-based treatments and could guide the development of future cancer immunotherapies.

16 Jul 2026

New Double Donut Structure Reveals How SPOP Protein Regulates Cancer

Mutations to the protein SPOP are widespread in cancer, yet many remain poorly understood. To address this gap, St. Jude Children's Research Hospital scientists obtained structures of SPOP in both the presence and absence of these mutations.

14 Jul 2026

GLP-1 Drugs Show Promise Against Long COVID-Related Lung Scarring

GLP-1 agonists have gained widespread use for managing weight loss and type 2 diabetes, with recent research indicating additional health advantages.

13 Jul 2026

Next-Generation Biosensing Shows How Bacteriophages Revolutionize Bacterial Disease Detection

Pathogenic bacteria remain a persistent threat to public health, food supplies, and water systems, particularly as antimicrobial resistance makes infections increasingly difficult to treat.

11 Jul 2026

Eradicating Lingering Cancer Cells Prevents Relapse in B Cell Leukemia

Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival outcomes, by treating with the antibody-drug conjugate (ADC) inotuzumab ozogamicin.

9 Jul 2026

New Aptamer Selection Strategy Streamlines Development of Safer Therapeutic Candidates

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, which regulate diverse physiological processes ranging from pain perception to hormone signaling.

8 Jul 2026

Antibody Drug Conjugate Treatment Destroys Hidden B Cell Leukemia

By using the antibody-drug conjugate (ADC) inotuzumab ozogamicin to treat B-cell acute lymphoblastic leukemia (ALL) patients, researchers at The University of Texas MD Anderson Cancer Center were able to eliminate measurable residual disease (MRD), a crucial step in enhancing long-term survival outcomes.

8 Jul 2026

Study: Genetically Engineered CAR T Cells Suppress the Immune System’s Response to Allergen

Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the immune system's response against leukemias and other cancers.

7 Jul 2026